BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12747581)

  • 1. Pharmacogenetics and pharmacogenomics in drug discovery and development: an overview.
    Lindpaintner K
    Clin Chem Lab Med; 2003 Apr; 41(4):398-410. PubMed ID: 12747581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and the future of medical practice.
    Lindpaintner K
    J Mol Med (Berl); 2003 Mar; 81(3):141-53. PubMed ID: 12682723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pharmacogenetics and pharmacogenomics on drug discovery.
    Lindpaintner K
    Nat Rev Drug Discov; 2002 Jun; 1(6):463-9. PubMed ID: 12119748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics, pharmacogenomics, and individualized medicine.
    Ma Q; Lu AY
    Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug target pharmacogenomics: an overview.
    Johnson JA
    Am J Pharmacogenomics; 2001; 1(4):271-81. PubMed ID: 12083959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of genomics on anti-infectives drug discovery and development.
    Parkinson T
    Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DrugBank and its relevance to pharmacogenomics.
    Wishart DS
    Pharmacogenomics; 2008 Aug; 9(8):1155-62. PubMed ID: 18681788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and the future of medical practice.
    Lindpaintner K
    Br J Clin Pharmacol; 2002 Aug; 54(2):221-30. PubMed ID: 12207645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop.
    Lesko LJ; Salerno RA; Spear BB; Anderson DC; Anderson T; Brazell C; Collins J; Dorner A; Essayan D; Gomez-Mancilla B; Hackett J; Huang SM; Ide S; Killinger J; Leighton J; Mansfield E; Meyer R; Ryan SG; Schmith V; Shaw P; Sistare F; Watson M; Worobec A
    J Clin Pharmacol; 2003 Apr; 43(4):342-58. PubMed ID: 12723455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in pharmacogenomics and its promise for medicine.
    Blake CA; Sobel BE
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workshop outcomes report: initiatives to establish a European Network of pharmacogenetics/genomics and progress.
    Maitland-van der Zee AH; Aitchison K; Kirchheiner J;
    Eur J Pharm Sci; 2007 Jul; 31(3-4):151-5. PubMed ID: 17452095
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomics and personalized medicine.
    Meadows M
    FDA Consum; 2005; 39(6):12-7. PubMed ID: 16669113
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenetics in drug development.
    McCarthy AD; Kennedy JL; Middleton LT
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of pharmacogenomics research on drug development.
    Liou SY; Stringer F; Hirayama M
    Drug Metab Pharmacokinet; 2012; 27(1):2-8. PubMed ID: 22214937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics: integration into drug discovery and development.
    Johnson K; Thompson J; Power A
    Curr Top Med Chem; 2005; 5(11):1039-46. PubMed ID: 16181129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of pharmacogenetics.
    Katz DA
    Curr Protoc Hum Genet; 2006 May; Chapter 9():Unit 9.19. PubMed ID: 18428399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Integration of pharmacogenetics in the medical practice].
    Dideberg V; Bours V
    Rev Med Liege; 2005 Dec; 60(12):918-22. PubMed ID: 16457391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The era of genomics: impact on sepsis clinical trial design.
    Cariou A; Chiche JD; Charpentier J; Dhainaut JF; Mira JP
    Crit Care Med; 2002 May; 30(5 Suppl):S341-8. PubMed ID: 12004257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics and pharmacogenomics: are they still promising?
    Pirazzoli A; Recchia G
    Pharmacol Res; 2004 Apr; 49(4):357-61. PubMed ID: 15202515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.